Nivolumab comes in the form of a liquid to be injected into the vein over one hour. It is usually given once every two weeks. When administered with ipilimumab, it is given for once every three weeks.
Dosage & When it is to be taken
The recommended dose is 3mg/kg to be injected as an intravenous infusion over one hour. It is administered once every two weeks.
When it is not to be taken (Contraindications)
The medication is contraindicated if the patient is allergic to the drug and if the drug produces any serious reaction, with history of organ transplant, any autoimmune disease like Crohn’s disease, lung or liver disease, during pregnancy and breastfeeding.
Drug Name : Nivolumab
Nivolumab is a monoclonal antibody and a PD-1 inhibitor (programmed death receptor inhibitor) which is prescribed for cancer treatment.
